Sanofi to acquire Principia Biopharma
The late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases has entered into a definitive agreement with Sanofi
Breaking News
FairJourney enters antibody discovery agreement with Pandion
Pandion focuses on the development of modular therapeutics using its Talon (Therapeutic Autoimmune reguLatOry proteiN) ...
Lonza and Be The Match BioTherapies partner on CGT
The partnership will build on previous collaborations made by both companies
Pharming to build downstream processing facility in Oss
The facility will process the starting material for the company’s Ruconest product
Royal Society of Chemistry calls for R&D investment
The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...
Cambrex investing $50m at Charles City API facility
In 2019, Cambrex was acquired by funds advised by Permira, a global investment firm
SGS increases its capacity for human challenges studies
The company has 47 offices and laboratories with 3,600 employees, of which 600 work in the life sciences sector
Beximco Pharma: The Bangladeshi company connecting with the US
COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
Lonza expands HPAPI development and manufacturing in Tampa
The company has invested more than $15m to expand and upgrade the Tampa site capabilities over the last two years
Almac receives grant to accelerate COVID-19 treatment manufacture
This news comes six months after Almac announced it was supporting two COVID-19 clinical studies in Sub-Saharan Africa
The experiment: human versus machine
In this article Miha Možina, PhD, Business Developer at Sensum discusses why he believes investment decisions should ...
Addressing the need for cost-effective vaccine manufacturing
Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...
BioCity predicts proliferation of workspace amid life science ventures boom
The UK's life science incubator has released the Life Science Start-Up Report with in-depth analysis of emerging ...
Lead Pharma enters research collaboration with Roche
Under the terms of the agreement, Lead Pharma will receive an upfront payment of $8.44m
Onyx Scientific makes $3.96m UK facility investment
The facility is expected to be approximately 30,000 sqft and will be used for non-GMP & GMP Phase I – III and ...
In Brief
Most Popular in Finance
Featured Companies
Reports
